GGrantIndex
← Leaderboards

Sana D Karam

University Of Colorado Denver

$9,495,305
Attributed
$9,495,305
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.9M · FY201925
$2M$1.5M$1M$500K$0
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$9,495,305 · 5

By mechanism

R01$7,506,732 · 3
P50$1,665,324 · 1
T32$323,249 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Colorado Denver

Same institution · by research overlap

Others in their field

Other Emerging Leaders on “Head And Neck Cancer

Research focus

Head And Neck CancerCellsTumorCancer CellTherapy ResistantMediatingSignal TransductionCoculture TechniquesTumor MicroenvironmentMolecularTissuesPathway InteractionsStat3 GeneKnock-DownImmunofluorescence ImmunologicHead And Neck Squamous Cell CarcinomaClinical TrialsMalignant NeoplasmsGenetically Engineered MouseMouse ModelImmuneRegulatory T-LymphocyteResponseGenetic

Grant awards (22)

Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCC$693,401
R01 · FY2025 · CA · contact PI
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCC's$499,311
R01 · FY2025 · DE · contact PI
Targeting EphB4-ephrinB2 to decrease immunosuppression in HNSCC$343,092
P50 · FY2025 · CA · contact PI
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs$495,520
R01 · FY2024 · DE · contact PI
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCC$488,632
R01 · FY2024 · CA · contact PI
Targeting EphB4-ephrinB2 to decrease immunosuppression in HNSCC$323,204
P50 · FY2024 · CA · contact PI
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCC$118,383
R01 · FY2024 · CA · contact PI
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCC$646,344
R01 · FY2023 · CA · contact PI
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer$475,766
R01 · FY2023 · DE · contact PI
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs$439,092
R01 · FY2023 · DE · contact PI
Targeting EphB4-ephrinB2 to decrease immunosuppression in HNSCC$324,670
P50 · FY2023 · CA · contact PI
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer$471,009
R01 · FY2022 · DE · contact PI
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs$434,700
R01 · FY2022 · DE · contact PI
Targeting EphB4-ephrinB2 to decrease immunosuppression in HNSCC$324,855
P50 · FY2022 · CA · contact PI
Training in Translational Research of Lung, Head and Neck Cancer$323,249
T32 · FY2022 · CA · contact PI
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer$475,766
R01 · FY2021 · DE · contact PI
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs$439,092
R01 · FY2021 · DE · contact PI
Targeting EphB4-ephrinB2 to decrease immunosuppression in HNSCC$349,503
P50 · FY2021 · CA · contact PI
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer$475,766
R01 · FY2020 · DE · contact PI
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs$439,092
R01 · FY2020 · DE · contact PI
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancer$475,766
R01 · FY2019 · DE · contact PI
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCs$439,092
R01 · FY2019 · DE · contact PI